M1 and M2 Muscarinic Receptor Subtypes Regulate Antidepressant-Like Effects of the Rapidly Acting Antidepressant Scopolamine

Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice

Madhukar H. Trivedi, A. John Rush, Stephen R. Wisniewski et al. · American Journal of Psychiatry · 2006 · 3.9K citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Antidepressant effects of ketamine in depressed patients

Robert Berman, Angela Cappiello, Amit Anand et al. · Biological Psychiatry · 2000 · 3.8K citations

Medicine, Pharmacology, Psychiatry +14

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

Carlos A. Zarate, Jaskaran Singh, Paul J. Carlson et al. · Archives of General Psychiatry · 2006 · 3.8K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Behavioral despair in mice: a primary screening test for antidepressants.

Porsolt Rd, Aurélie Bertin, M Jalfre · PubMed · 1977 · 3.3K citations

Medicine, Pharmacology, Psychiatry +17

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

Nanxin Li, Boyoung Lee, Rongjian Liu et al. · Science · 2010 · 2.9K citations · Full text

Life Sciences, Neuroscience, Pharmacology +17